GliaPharm's Incubator/Accelerator Round

GliaPharm raised a round of funding on May 24, 2017. Investors include MassChallenge.

GliaPharm is a biotechnology company that develops treatments for neurological and psychiatric disorders. Its therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain …

Articles about GliaPharm's Incubator/Accelerator Round: